These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 7174325)

  • 21. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthermic isolated regional perfusion of the limb with carboplatin.
    Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ
    Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regional hyperthermic perfusion--therapeutic concept and long term results].
    Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1992; ():494-501. PubMed ID: 1493314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
    J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional chemotherapy by isolation-perfusion.
    McBride CM; McMurtrey MJ; Copeland EM; Hickey RC
    Int Adv Surg Oncol; 1978; 1():1-9. PubMed ID: 553035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

  • 37. TNF-based limb perfusion for cutaneous melanoma in transit metastases: suggestions for modification of the perfusional schedule.
    Rossi CR; Foletto M; Mocellin S; Pilati PL; Campana L; Rubello D; Lise M
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):103-7. PubMed ID: 16767915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.
    Vaglini M; Belli F; Marolda R; Prada A; Santinami M; Cascinelli N
    Eur J Surg Oncol; 1987 Apr; 13(2):127-9. PubMed ID: 3556593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value?].
    Meyer T; Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1452-4. PubMed ID: 9931909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.